Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON41353
NL-OMON41353
Completed
Not Applicable

Randomized controlled trial of neurostimulation treatment for apathy in schizophrenia - Neurostimulation as a treatment of apathy with vulnerability for psychosis

niversitair Medisch Centrum Groningen0 sites150 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsapathylistlessnesspsychosis10039628

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
apathy
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
150
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •\- At least 18 y.o.a.
  • •\- Diagnosis schizophrenia, according to DSM IV
  • •\- Minimum score AES (27\)
  • •\- Written informed consent
  • •Healthy subjects:
  • •\- At least 18 y.o.a.
  • •\- written informed consent

Exclusion Criteria

  • •\-Metal implants (pacemaker, heart valves, vascular clips, eye\-implants, copper containing intra\-uterine devices, or non\-removable piercing)
  • •\- Any risk of having metal particles in the eyes due to manual work without proper eye protections \- Tattoos containing iron oxide (often found in red pigments)
  • •\- (suspected) Pregnancy
  • •\- Claustrophobia
  • •\- Refused to be informed (via the general practisioner of the patient) of structural brain abnormalities that could be detected during the experiment;TMS:
  • •\- Diagnosis of epilepsy, or a personal or first degree family history of epileptic seizures
  • •\- Medications associated with increased seizure risk
  • •\- Brain surgery
  • •\- Neurological problems in the past or at present
  • •\- Intracerebral implants;tDCS:

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
A treatmentstudy for apathy in schizophrenia.*Apathy - apathie*Cognitive functioning - cognitief functioneren*Schizophrenia - schizofrenie
NL-OMON20441Geld van Ministerie van OC&W aan universiteiten125
Recruiting
Not Applicable
**NeuroCue*, a randomized controlled study into the use of an electronic cognitive aid in patients with acquired brain injury*cognitive disorders after brain injury/problems with memory and planning after brain damage1004225810009841
NL-OMON33708niversiteit Maastricht140
Completed
Phase 1
Tactile stimulus for the prevention of low blood oxygen immediately after surgeryHypoxemiaCirculatory System
ISRCTN89522367Mayo Clinic100
Recruiting
Phase 2
Randomized controlled trial for peripheral neuropathy comparing weekly Paclitaxel followed by FEC100 with Eribulin Mesilate followed by FEC100 as neoadjuvant chemotherapy in primary breast cancer patients.Operable early Breast Cancer
JPRN-UMIN000012817JONIE Study Group230
Completed
Not Applicable
on-pharmacological techniques for cognitive improvement in schizophreniaSchizophrenia
RBR-69g952niversidade Federal de São Paulo